300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
United States
India
Germany
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Azerbaijan
Bulgaria
Ethiopia
Jordan
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Ecuador
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 5 Biotech VC Funds & Investors in Cayman Islands (September 2026)

The most active venture capital funds investing in Cayman Islands Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Cayman Islands Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Longpan Investment
VC Fund
2 China, United States, Cayman Islands Series A, Seed, Series B Health Care, Medical, Biotechnology $14M–$60M
Delian Capital
VC Fund
2 China, United States, France Series A, Seed, Series B Biotechnology, Manufacturing, Health Care $1.5M–$50M
Apricot Capital
VC Fund
1 United States, China, Malaysia Seed, Series A, Angel Health Care, Biotechnology, Advertising $1M–$10M
RiverHead Capital
VC Fund
1 China, United States, Cayman Islands Series A, Series B, Series C Health Care, Medical, Biotechnology $1.5M–$283M
Shanghai Sinobioway Sunterra Biotechnology
VC Fund
1 Cayman Islands Venture - Series Unknown Medical, Big Data, Health Care
Access all 25 VC funds in Cayman Islands Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Longpan Investment
VC Fund · Beijing, Beijing, China · 2 investments in Cayman Islands Biotech startups, 13 in the past 12 months

Longpan Investment is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Cayman Islands

Investor stats

  • Total investments: 44
  • Round size: Seed $14M–$60M; Series A $14M–$32M; Series B $14M–$37M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Jingling Zhikang — Jingling Zhikang is technology company specializing in the intersection of medical rehabilitation, robotics, and embodied artificial intelligence. The company focuses on developing intelligent rehabilitation bionic hands and upper-limb prosthetics.
  • Hanyue New Materials — Hanyue Advanced Materials is a high-tech company that specializes in single-use biopharmaceutical solutions.
  • Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Show all investments...

Delian Capital
VC Fund · Beijing, Beijing, China · 2 investments in Cayman Islands Biotech startups, 15 in the past 12 months

Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, France

Investor stats

  • Total investments: 100
  • Round size: Seed $1.5M–$50M; Series A $1.6M–$20M; Series B $9.9M–$30M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • GeneMind Biosciences — GeneMind Biosciences is a domestic third-generation single-molecule gene sequencing system. GeneMind Biosciences has been fighting to provide better gene sequencing solutions for clinicians and researchers. A Gene sequencer is the crown jewel in the field of gene sequencing. Entrepreneurs will lead their innovations and breakthroughs throughunremitting research and exploration. GeneMind believes that the strong pass of the difficulty is like a wall of iron, yet with firm strides, we are conquering its summit.
  • Micronano Core — Micro-nano core is committed to the development and production of the world's leading intelligent IoT AIoT SoC serialized chips, through the world's leading four core technologies: ultra-low-power chip architecture technology (to solve the problem of system standby power consumption), ultra-low power consumption Power consumptionclosed-loop adaptive near-threshold circuit technology (to solve the problem of chip running power consumption), ultra-low power consumption and high-precision sensor acquisition technology (to solve the problem of high precision and low power consumption of sensor signal acquisition) and high-efficiency embedded AI engine technology (solving the computing power and energy efficiency of embedded AI), creating a general/platform technology system for IoT chips and AIoT serialized chips, enabling IoT products, and significantly improving the low power consumption, low power consumption, and low power consumption of future IoT products High-precision detection and edge AI inference performance.
  • Yanhe Technology — Yanhe Technology provides solar power generation technology-related services.
Show all investments...

Apricot Capital
VC Fund · Boston, Massachusetts, United States · 1 investments in Cayman Islands Biotech startups

Apricot Capital is a seed stage investment firm based in Boston, MA and Toronto, Canada. Investments: awe.sm, Careport Health, Clypd, Crashlytics (acquired 2012), Habit Labs, Kinvey, Massive Damage, Momentfeed, MyTime, OnSwipe, Placester, Smart Lunches, TribeHR (acquired 2013), Peekaboo Mobile (acquired 2011)

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Advertising
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Malaysia

Investor stats

  • Total investments: 10
  • Round size: Seed $1M–$10M; Series A $1.1M–$3.2M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Kind Kones — We deliver plant-based ice cream and wholesome treats!
  • D2M Biotherapeutics — D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.
  • ClinChoice — Fountain Medical Development Ltd., a contract research organization, provides ICH GCP compliant clinical research services for the multinational clients in China and the United States. It offers consulting, project management, regulatory affairs, clinical operations, central laboratory services, site management, biometrics, and clinical trialdesigns, as well as AE/SAE collection, review, assessment and reporting services, data and safety monitoring board handling, and signal detection services. The company is based in Beijing, China.
Show all investments...

RiverHead Capital
VC Fund · Chaoyang, Liaoning, China · 1 investments in Cayman Islands Biotech startups, 9 in the past 12 months

River Head Capital is the private equity arm of the Sunshine Insurance Group.River Head Capital was established in January 2015. It is the first batch of insurance private fund pilot units approved by the China Insurance Regulatory Commission. The fund management scale has reached 17 billion yuan.Adhering to the corporate vision of “making lifebetter”, with the mission of “creating value, trustworthiness, investing resources in the most valuable companies, and gaining the trust of investors with excellent returns”, the company will actively deploy medical health and emerging Industries, emerging consumption, industrial mergers and acquisitions, real estate and other fields, through entrepreneurial support, strategic investment, financial investment, mergers and acquisitions, corporate restructuring, cross-border investment and other diversified ways to invest in enterprises, comprehensively enhance corporate value and support the healthy and sustainable development of enterprises. At present, River Head Capital has invested in a number of companies in the fields of medical, pharmaceutical, Internet, and innovative financial services.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Cayman Islands

Investor stats

  • Total investments: 44
  • Round size: Series A $1.5M–$74M; Series B $14M–$283M; Series C $15M–$89M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $295M in 2023

Portfolio highlights

  • SiranBio — SiranBio is a biotechnology that develops innovative siRNA drugs.
  • Delova Biotech — Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States.
  • Linghang Huaxin — Linghang Huaxin is a semiconductor technology company. It focuses on the research and development of high-reliability memory chips and modules.
Show all investments...

Shanghai Sinobioway Sunterra Biotechnology
VC Fund · Shanghai, Shanghai, China · 1 investments in Cayman Islands Biotech startups

Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies. It was formed by Sinobioway Group, Sunterra Capital, and F1 Oncology for the express purpose of developing novel CAB-CAR-T therapies for solid tumor malignancies in China. SSSB's GMP cell processingfacilities in Shanghai have been developed to support clinical research through key academic collaborations.

Show more...

Investment focus

  • Industry: Medical, Big Data, Health Care
  • Stage:Venture - Series Unknown
  • Geography: Cayman Islands

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Exuma Biotech — EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
Show all investments...

Biotech VC funding in Cayman Islands at a glance

Stats across 15 deals from 25 investors.

25
investors
in Cayman Islands Biotech startups
15
deals
in Cayman Islands Biotech startups
$25M
median round
in Cayman Islands Biotech startups
40%
lead investors
lead at least one round
27%
Post-IPO Equity
most common funding stage

Access all 25 VC funds in Cayman Islands Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Cayman Islands investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 25 VC funds investing in Cayman Islands Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists